Modular Prevention Bundle for Non-ventilator-associated Hospital-acquired Pneumonia (nvHAP)
NCT03361085 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45000
Last updated 2020-07-14
Summary
Background: Hospital acquired pneumonia (HAP) is divided in two distinct groups, ventilator-associated pneumonia (VAP) and non-ventilator-associated HAP (nvHAP). Although nvHAP occurs more frequently than VAP and results in similar mortality and costs, prevention guidelines and prevention focus almost exclusively on VAP. Scientific evidence about nvHAP prevention is scarce. Therefore, we designed a mixed-methods study to investigate the effectiveness of a newly developed nvHAP prevention bundle and factors that influence its implementation.
Methods: This single-centre project at the 950-bed University Hospital Zurich (UHZ) will engage the wards of nine departments with substantial nvHAP rates. The nvHAP bundle consists of five primary prevention measures: 1) oral care, 2) identification and treatment of patients with dysphagia, 3) mobilization, 4) stopping unnecessary proton pump inhibitors, and, 5) respiratory therapy. Implementation includes the engagement of department-level implementation teams, who sustain the 'core' intervention components of education, training, and environmental restructuring and adapt the implementation strategy to local needs. The effects of the implementation will be analysed by a mixed-method approach. As primary outcome, nvHAP incidence rates will be analysed by Poisson regression models to compare incidence rates before, during, and after the implementation phases (on the hospital and department level). In addition, the association between process indicators and nvHAP incidence rates will be analysed using longitudinal Poisson regression models. A longitudinal, qualitative study and formative evaluation based on interviews and focus groups identifies supporting or hindering factors for implementation success in participating departments dynamically over time. This accumulating implementation experience will be constantly fed back to the implementation teams and thus, represents an active implementation element.
Discussion: This comprehensive mixed-methods study is designed to accomplish both, measure the effectiveness of a new prevention bundle against nvHAP and provide insights into how and why it worked or failed. The results of this study may contribute substantially to patient safety in the area of a rediscovered healthcare-associated infection - nvHAP.
Conditions
- Hospital-acquired Pneumonia
- Healthcare Associated Infection
- Infection Prevention
Interventions
- PROCEDURE
-
nvHAP Prevention Bundle
oral care, (early) mobilization, diagnosis and treatment of dysphagia, respiratory physiotherapy, stop Proton pump Inhibitors (PPI) if reasonable
Sponsors & Collaborators
-
University of Zurich
lead OTHER
Principal Investigators
-
Aline Wolfensberger, MD · University of Zurich
-
Lauren Clack, PhD · University of Zurich
Study Design
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-01
- Primary Completion
- 2020-02-28
- Completion
- 2020-02-28
Countries
- Switzerland
Study Locations
More Related Trials
-
Immediate Versus Substantiated Antibiotic Therapy in Suspected Non-Severe Ventilator-Associated Pneumonia
NCT06743529 ·Status: RECRUITING ·Phase: NA
-
Empiric Antibiotic Therapy for Ventilator-acquired Pneumonia With Gram-negative Bacilli in Intensive Care
NCT02127528 ·Status: UNKNOWN
-
Defining Antibiotic Treatment Duration for Ventilator - Associated Lung Infection
NCT03382548 ·Status: COMPLETED ·Phase: PHASE3
-
The Pharmacodynamics of Doripenem Between 4-hour and 1-hour Infusion in Patients With Ventilator-associated Pneumonia
NCT01467648 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Antibio Prophylaxis on Occurence of Ventilator Associated Pneumonia in Trauma Patients
NCT07059039 ·Status: COMPLETED
-
Aerosolized Antibiotics in the Treatment of Ventilator Associated Pneumonia
NCT02478710 ·Status: TERMINATED ·Phase: PHASE4
-
Antimicrobial Stewardship For Ventilator Associated Pneumonia in Intensive Care
NCT05124977 ·Status: RECRUITING ·Phase: NA
-
Hospital-acquired Pneumonia Prevention: Intervention, Evaluation & Research
NCT04915898 ·Status: COMPLETED ·Phase: NA
-
Microbial Etiology of Ventilator-associated Pneumonia in COVID-19 Infected Patients
NCT04344509 ·Status: UNKNOWN
-
Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches
NCT04410263 ·Status: UNKNOWN
-
Methods of Chlorhexidine Cleansing to Prevent Ventilator-Associated Pneumonia (VAP)
NCT02077920 ·Status: COMPLETED ·Phase: PHASE2
-
Nebulized Amikacin Versus Intravenous Amikacin in the Treatment of Nosocomial Pneumonia
NCT02728518 ·Status: COMPLETED ·Phase: NA
-
Can we Better Understand the Development of VAP and Eventually Predict and Prevent it?
NCT01875692 ·Status: COMPLETED
-
Direct E-test on Bronchoalveolar Lavage From Patients With Ventilator-acquired Pneumonia
NCT01042353 ·Status: COMPLETED ·Phase: PHASE4
-
Ventilation Associated Pneumonia and Covid-19
NCT05089968 ·Status: COMPLETED
-
Antimicrobial Stewardship Program and Ventilator Associated Pneumonia
NCT04097899 ·Status: COMPLETED
-
Five Versus Seven Day Antibiotic Course for the Treatment of Pneumonia in the Intensive Care Unit
NCT01554657 ·Status: COMPLETED ·Phase: NA
-
Early Antibiotics After Aspiration in ICU Patients
NCT05079620 ·Status: TERMINATED ·Phase: PHASE4
-
Respiratory Infection in Older Patients
NCT04347395 ·Status: COMPLETED ·Phase: NA
-
Structural and Microbiological Characterization of Endotracheal Tube Biofilm in Patients at Increased Risk for the Development of Ventilator-associated Pneumonia in the Intensive Care Unit
NCT04926493 ·Status: COMPLETED
-
Ventilator Associated Pneumonia Multiplex PCR for Anti-Infective Regimens
NCT06554327 ·Status: RECRUITING ·Phase: NA
-
Lipid Kinetics of Patients With Pneumonia
NCT04748432 ·Status: COMPLETED
-
Inhaled Polymyxin E to Prevent VAP
NCT06819462 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Can Hospital Acquired Pneumonia be Prevented in Patients Who Gurgle?
NCT01134133 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
7-days Versus 14 Days of Antibiotics Therapy for Ventilator Associated Pneumonia
NCT03477292 ·Status: COMPLETED ·Phase: NA